SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 213 filers reported holding SAGE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,476,984 | +30.0% | 411,904 | +197.1% | 0.05% | +35.1% |
Q2 2023 | $6,519,182 | -6.3% | 138,647 | -16.3% | 0.04% | -21.3% |
Q1 2023 | $6,954,073 | +11.3% | 165,731 | +1.1% | 0.05% | -9.6% |
Q4 2022 | $6,249,506 | -3.3% | 163,857 | -0.7% | 0.05% | -24.6% |
Q3 2022 | $6,460,000 | +105.2% | 164,953 | +69.2% | 0.07% | +137.9% |
Q2 2022 | $3,148,000 | -45.5% | 97,462 | -44.2% | 0.03% | -14.7% |
Q1 2022 | $5,778,000 | -2.1% | 174,548 | +25.8% | 0.03% | +9.7% |
Q4 2021 | $5,903,000 | +83.0% | 138,756 | +90.6% | 0.03% | +40.9% |
Q3 2021 | $3,225,000 | +72.2% | 72,793 | +120.8% | 0.02% | +83.3% |
Q2 2021 | $1,873,000 | -40.9% | 32,974 | -22.1% | 0.01% | -45.5% |
Q1 2021 | $3,168,000 | +171.2% | 42,328 | +213.5% | 0.02% | +100.0% |
Q4 2020 | $1,168,000 | -46.3% | 13,502 | -62.1% | 0.01% | -57.7% |
Q3 2020 | $2,176,000 | +98.4% | 35,603 | +35.0% | 0.03% | +73.3% |
Q2 2020 | $1,097,000 | -71.8% | 26,379 | -51.0% | 0.02% | -75.0% |
Q4 2019 | $3,886,000 | -31.7% | 53,837 | +32.7% | 0.06% | -32.6% |
Q3 2019 | $5,690,000 | +9.5% | 40,561 | +43.0% | 0.09% | -2.2% |
Q2 2019 | $5,195,000 | -0.6% | 28,372 | -13.7% | 0.09% | +8.3% |
Q1 2019 | $5,227,000 | – | 32,864 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DAFNA Capital Management LLC | 99,306 | $14,027,000 | 5.76% |
Casdin Capital, LLC | 312,000 | $44,070,000 | 5.36% |
Palo Alto Investors LP | 840,372 | $118,703,000 | 4.80% |
BB BIOTECH AG | 1,071,373 | $151,331,000 | 4.00% |
TRV GP II, LLC | 37,362 | $5,277,000 | 3.10% |
Eversept Partners, LP | 43,621 | $6,161,466 | 2.70% |
RA Capital Management | 350,933 | $49,569,000 | 2.65% |
Eventide Asset Management | 494,000 | $69,778,000 | 2.56% |
OAK RIDGE INVESTMENTS LLC | 241,099 | $34,055,000 | 1.88% |
SUFFOLK CAPITAL MANAGEMENT LLC | 93,000 | $13,136,000 | 1.87% |